Sp686
STATE-OF-THE ART PRESENTATION: GASTRIC ESD - WHAT'S NEW IN 2024?
Date
May 19, 2024
Presenter
Mayo Clinic Arizona
Tracks
Related Products
NOVEL TECHNOLOGY AND NEW TRANS-ANAL PLATFORM TO EXCISE A COMPLEX LEFT COLONIC LESION AND PREVENT LUMINAL NARROWING
BACKGROUND: Malnutrition is a complication of Roux-en-Y gastric bypass (RYGB) and can range from micronutrient deficiencies to protein-calorie malnutrition. Malignant neoplasms and certain surgical complications can increase this risk…
ENDOSCOPIC TRANSESOPHAGEAL RETROGRADE DRAINAGE TANDEM WITH ENDOSCOPIC CLOSURE FOR MANAGEMENT OF ESOPHAGEAL LEAK AFTER PERORAL ENDOSCOPIC MYOTOMY FOR ZENKER’S DIVERTICULUM
Gastric fistula formation is a known complication of bariatric surgery. Many gastric fistulae can be managed endoscopically, however, it can be difficult to successfully treat chronic fistulae…
OUTCOMES OF SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION FOR SUBEPITHELIAL TUMORS IN THE UPPER GASTROINTESTINAL TRACT: EXPERIENCE FROM THE UNITED STATES
BACKGROUND: G-POEM has emerged as a treatment for medically refractory gastroparesis. Safe and effective mucosal closure is necessary to avoid potential morbidity…
RECTAL NSAIDS FOR POST-ERCP PANCREATITIS PROPHYLAXIS AND RISK OF ACUTE KIDNEY INJURY
Rectal non-steroidal anti-inflammatory drugs (NSAIDs) reduce post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). There is limited data regarding the risk of acute kidney injury (AKI) with one-time rectally administered NSAIDs (NSAID-PR)…
